Haruhiko Hirata

4.0k total citations
87 papers, 1.2k citations indexed

About

Haruhiko Hirata is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Haruhiko Hirata has authored 87 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Haruhiko Hirata's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers). Haruhiko Hirata is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers). Haruhiko Hirata collaborates with scholars based in Japan, United States and United Kingdom. Haruhiko Hirata's co-authors include Atsushi Kumanogoh, Yoshito Takeda, Izumi Nagatomo, Hiroshi Kida, Kota Iwahori, Takashi Kijima, Takayuki Shiroyama, Kotaro Miyake, Isao Tachibana and Makoto Matsumoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Haruhiko Hirata

79 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haruhiko Hirata Japan	16	353	316	310	208	207	87	1.2k
Chong Wang China	21	520 1.5×	233 0.7×	404 1.3×	271 1.3×	65 0.3×	69	1.4k
Atsushi Otsuka Japan	22	199 0.6×	517 1.6×	271 0.9×	171 0.8×	48 0.2×	147	1.7k
Masachika Fujiwara Japan	20	354 1.0×	436 1.4×	472 1.5×	95 0.5×	44 0.2×	132	1.4k
Hirohisa Ogawa Japan	24	352 1.0×	399 1.3×	556 1.8×	276 1.3×	45 0.2×	89	1.6k
Jiří Štork Czechia	21	290 0.8×	96 0.3×	433 1.4×	247 1.2×	80 0.4×	56	1.2k
Hidenori Kawasaki Japan	18	145 0.4×	388 1.2×	180 0.6×	69 0.3×	86 0.4×	64	982
Heike Göbel Germany	17	150 0.4×	181 0.6×	322 1.0×	248 1.2×	53 0.3×	56	1.1k
Jin Zhou China	19	163 0.5×	149 0.5×	262 0.8×	299 1.4×	52 0.3×	53	1.0k
Cornelia M. Gelbmann Germany	23	219 0.6×	489 1.5×	214 0.7×	238 1.1×	48 0.2×	52	1.7k
Atsushi Imamura Japan	21	221 0.6×	217 0.7×	659 2.1×	68 0.3×	75 0.4×	88	1.4k

Countries citing papers authored by Haruhiko Hirata

Since Specialization

Citations

This map shows the geographic impact of Haruhiko Hirata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhiko Hirata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhiko Hirata more than expected).

Fields of papers citing papers by Haruhiko Hirata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruhiko Hirata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhiko Hirata. The network helps show where Haruhiko Hirata may publish in the future.

Co-authorship network of co-authors of Haruhiko Hirata

This figure shows the co-authorship network connecting the top 25 collaborators of Haruhiko Hirata. A scholar is included among the top collaborators of Haruhiko Hirata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruhiko Hirata. Haruhiko Hirata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adachi, Yuichi, Kotaro Miyake, S. Satoh, et al.. (2025). Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44–targeting antibody–photoabsorber conjugates. EBioMedicine. 112. 105566–105566.

Miyake, Kotaro, Masahide Oki, Hidekazu Suzuki, et al.. (2025). Balloon Dilatation for Bronchoscope Delivery: First-in-Human Trial of a Novel Technique for Ultra-peripheral Lung Field Access. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2731–A2731.

Hoshino, Taiki, Akinori Uchiyama, Natsuko Tokuhira, et al.. (2023). Factors Associated With Prolonged Ventilation in Patients Receiving Prone Positioning Protocol With Muscle Relaxants for Severe COVID-19 Pneumonia. Respiratory Care. 68(8). 1075–1086.

Kawata, Satoshi, Junji Kozawa, S. Yoneda, et al.. (2023). Inflammatory Cell Infiltration Into Islets Without PD-L1 Expression Is Associated With the Development of Immune Checkpoint Inhibitor–Related Type 1 Diabetes in Genetically Susceptible Patients. Diabetes. 72(4). 511–519. 12 indexed citations

Yoshimura, Jumpei, Takeshi Ebihara, Hisatake Matsumoto, et al.. (2023). Classification of patients with COVID-19 by blood RNA endotype: a prospective cohort study. Microbiology Spectrum. 11(6). e0264523–e0264523. 1 indexed citations

Søndergaard, Jonas Nørskov, Ryuya Edahiro, Yuya Shirai, et al.. (2023). A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients. Proceedings of the National Academy of Sciences. 120(4). e2217902120–e2217902120. 10 indexed citations

Abe, Yuko, Kotaro Miyake, Takayuki Shiroyama, et al.. (2023). Virtual fluoroscopic preprocedural planning using Ziostation2 for transbronchial biopsy: A prospective self-controlled study. Respiratory Investigation. 61(2). 157–163. 1 indexed citations

Ebihara, Takeshi, Tsunehiro Matsubara, Hisatake Matsumoto, et al.. (2022). Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients. Journal of Clinical Immunology. 43(2). 286–298. 10 indexed citations

Matsumoto, Hisatake, Jumpei Yoshimura, Tsunehiro Matsubara, et al.. (2022). Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients. Molecular Therapy — Nucleic Acids. 29. 343–353. 13 indexed citations

10.

Matsumoto, Kinnosuke, Takayuki Shiroyama, Kotaro Miyake, et al.. (2022). Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma. Medicine. 101(1). e28476–e28476. 4 indexed citations

11.

Hayashi, Kazuhiko, Осаму Сузукі, Hiroya Shiomi, et al.. (2021). Stereotactic Ablative Radiotherapy Using CyberKnife for Stage I Non-small-cell Lung Cancer: A Retrospective Analysis. Anticancer Research. 42(1). 321–327. 3 indexed citations

12.

Osa, Akio, Takeshi Uenami, Yujiro Naito, et al.. (2019). Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis. Thoracic Cancer. 10(11). 2183–2187. 10 indexed citations

13.

Hirata, Haruhiko, et al.. (2017). SHAKING TABLE TEST AND ULTIMATE SEISMIC BEHAVIOR ON PASSIVE CONTROLLED WOODEN FRAME. Journal of Structural and Construction Engineering (Transactions of AIJ). 82(733). 383–393.

14.

Matsunaga, Keiko, Masahiro Yanagawa, Tomoyuki Otsuka, et al.. (2017). Quantitative pulmonary blood flow measurement using 15O-H2O PET with and without tissue fraction correction: a comparison study. EJNMMI Research. 7(1). 102–102. 11 indexed citations

15.

Kijima, Takashi, Hiromitsu Sumikawa, Osamu Honda, et al.. (2014). A Retrospective Study of Prognostic Factors in Patients with Interstitial Pneumonia Receiving Long-Term Oxygen Therapy. Lung. 192(5). 729–737. 4 indexed citations

16.

Tetsumoto, Satoshi, Takashi Kijima, Eiichi Morii, et al.. (2013). Echinoderm Microtubule-Associated Protein-Like 4 (EML4)–Anaplastic Lymphoma Kinase (ALK) Rearrangement in Congenital Pulmonary Airway Malformation. Clinical Lung Cancer. 14(4). 457–460. 8 indexed citations

17.

Minami, Toshiyuki, Takashi Kijima, Yasushi Otani, et al.. (2012). HER2 As Therapeutic Target for Overcoming ATP-Binding Cassette Transporter–Mediated Chemoresistance in Small Cell Lung Cancer. Molecular Cancer Therapeutics. 11(4). 830–841. 24 indexed citations

18.

Takahashi, Ryo, Haruhiko Hirata, Isao Tachibana, et al.. (2011). Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung. Clinical Cancer Research. 18(1). 220–228. 78 indexed citations

19.

Tetsumoto, Satoshi, Akio Osa, Takashi Kijima, et al.. (2011). Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib. International Journal of Clinical Oncology. 17(2). 155–159. 14 indexed citations

20.

Kumanogoh, Atsushi, Chie Watanabe, Xiaosong Wang, et al.. (2000). Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100. Immunity. 13(5). 621–631. 285 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact